Daxor is a leading company in New York, NY that specializes in blood volume measurement. With over 65,000 tests performed and over 140 peer-reviewed studies confirming its value, Daxor's BVA-100 Blood Test provides accurate measurement of total blood, plasma, and red cell volume, leading to better patient outcomes. Their innovative technology is used in major centers across the U.S. and has been proven to significantly reduce heart failure mortality and readmissions, improve ICU survival, and enable volume-guided management.
Daxor's blood volume measurement is applicable in various medical and surgical conditions, including heart failure, critical care, sepsis, syncope, surgical blood loss, and ARDS. Their cost-effective approach has been approved for reimbursement and has been shown to positively impact the quality of care for providers, reduce healthcare costs for payers, and optimize treatment for patients. With a focus on innovation and research, Daxor collaborates with leading institutions such as Columbia University, Mayo Clinic, and Yale University to further establish the value of blood volume measurement in healthcare.
Generated from the website